Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
33.74
-1.66 (-4.69%)
At close: Apr 28, 2026, 4:00 PM EDT
33.09
-0.65 (-1.93%)
After-hours: Apr 28, 2026, 5:37 PM EDT
Rapport Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 30.31 | 22.12 | 8.18 | 1.37 |
| Research & Development | 94.79 | 60.94 | 28 | 4.49 |
| Operating Expenses | 125.1 | 83.06 | 36.18 | 5.85 |
| Operating Income | -125.1 | -83.06 | -36.18 | -5.85 |
| Interest Expense | - | - | - | -0.31 |
| Interest & Investment Income | 13.62 | 12.14 | 2.53 | - |
| EBT Excluding Unusual Items | -111.48 | -70.92 | -33.65 | -6.17 |
| Other Unusual Items | - | -7.39 | -1.12 | - |
| Pretax Income | -111.48 | -78.31 | -34.78 | -11.62 |
| Income Tax Expense | - | - | 0.01 | - |
| Net Income | -111.48 | -78.31 | -34.79 | -11.62 |
| Net Income to Common | -111.48 | -78.31 | -34.79 | -11.62 |
| Shares Outstanding (Basic) | 39 | 21 | 2 | 1 |
| Shares Outstanding (Diluted) | 39 | 21 | 2 | 1 |
| Shares Change (YoY) | 87.74% | 1277.25% | 93.74% | - |
| EPS (Basic) | -2.86 | -3.78 | -23.10 | -14.95 |
| EPS (Diluted) | -2.86 | -3.78 | -23.10 | -14.95 |
| Free Cash Flow | -88.09 | -67.23 | -28.82 | -3.85 |
| Free Cash Flow Per Share | -2.26 | -3.24 | -19.14 | -4.95 |
| EBITDA | -124.08 | -82.22 | -36.07 | -5.84 |
| D&A For EBITDA | 1.02 | 0.84 | 0.11 | 0.02 |
| EBIT | -125.1 | -83.06 | -36.18 | -5.85 |
Source: S&P Capital IQ. Standard template.
Financial Sources.